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www.aacrQuestions exist concerning the effects of acute versus chronic hypoxic conditions on DNA replication and
genomic stability that may influence tumorigenesis. Severe hypoxia causes replication arrest independent of
S-phase checkpoint, DNA damage response, or transformation status. Arrests occur during both the initiation
and elongation phases of DNA replication, correlated with a rapid decrease in available deoxynucleotide tri-
phosphates. With fluctuating oxygen tensions in tumors, arrested hypoxic cells may undergo rapid reperfusion
and reoxygenation that leads to reoxygenation-induced DNA damage. In cells subjected to chronic hypoxia, we
found that replicative restart was inhibited along with numerous replication factors, including MCM6 and
RPA, the latter of which limits the hypoxia-induced DNA damage response. In contrast, in cells where repli-
cative restart occurred, it was accompanied by extensive reoxygenation-induced DNA damage and compro-
mised DNA repair. We found that cells reoxygenated after acute hypoxia underwent rapid p53-dependent
apoptosis. Our findings suggest that cells lacking functional p53 are more susceptible to genomic instability
and potentially tumorigenesis if they experience reoxygenation after acute exposure to hypoxia. Cancer Res;
70(3); 925–35. ©2010 AACR.Introduction
Regions of hypoxia occur in all solid tumors as a result
of an abnormally formed tumor vasculature and inade-
quate perfusion of the tumor mass. The occurrence of re-
gions of low oxygen is an indicator of poor patient
prognosis due to increased chemo- and radio-resistance,
genomic instability, and metastatic potential (1, 2). The oc-
currence of episodes of reoxygenation following hypoxic
exposures of various degrees is inherent to the dynamic
nature of the tumor vasculature (3, 4). The range of oxy-
gen tensions within a tumor varies between approximately
8% and 0.02% (near anoxia, 100–150 μm from blood ves-
sels; ref. 5). Previous reports showed that severe hypoxia
(pO2 <0.02%) induces an S-phase arrest due to inhibition
of DNA synthesis in a HIF-1–independent manner (6, 7).
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journals.orgkinases ataxia telangiectasia mutated (ATM) and ATM-
related (ATR) and phosphorylation of downstream targets
such as p53, Chk1, and Chk2, albeit in the absence of de-
tectable DNA damage (6, 8, 9). In contrast, reoxygenation
was shown to rapidly induce DNA damage and, conse-
quently, a more conventional Chk2-dependent DDR leading
to a G2-M arrest (10, 11). Replicative stress and the subse-
quent induction of the DDR occur early in tumorigenesis
and have been proposed to act as a barrier to tumor pro-
gression (12, 13). It has been suggested that hypoxia could
contribute to this because hypoxic regions can form in
preneoplastic lesions (13, 14).
In this study, we have characterized the hypoxia-induced
S-phase arrest, showing that, at the molecular level, it is
associated with an inhibition of DNA replication in both
the initiation and elongation phases. Chronic hypoxia expo-
sure actively induces disassembly of the replisome, prevent-
ing replication restart after reoxygenation. However, acutely
exposed cells are still able to restart replication despite the
presence of an active checkpoint response and reoxygena-
tion-induced DNA damage. In a tumor, whereas regions of
chronic hypoxia cells eventually die and undergo necrosis,
replication restart in regions acutely subjected to low oxygen
could potentially lead to an accumulation of unrepaired
lesions and increased genomic instability (15). This is further
aggravated by hypoxia-dependent decreased DNA repair
(16). Our findings highlight the critical role of hypoxia in
tumor progression and indicate that under chronic condi-
tions, hypoxia can limit tumor progression, whereas under
acute conditions, cycles of hypoxia-reoxygenation increase
genomic instability.925
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926Materials and Methods
Cell lines. RKO, HCT116, and U2OS cells were grown in
DMEM with 10% FCS; IBR3 and IBR3 hTert were grown in
DMEM with 15% FCS. RKO-neo and RKO-E7 lines were a
gift from Dr. Kathleen Cho (University of Michigan, Ann
Arbor, MI). HCT116 spheroids were grown for 15 d by add-
ing single-cell suspensions obtained from exponential cul-
tures to spinning flasks (4 × 106 total cells). Pimonidazole
(1 μmol/L) was added 24 h before fixation. All cell lines
were Mycoplasma-free.
Hypoxia treatment. Hypoxia treatments were carried out
in a Bactron II anaerobic chamber (Shell Labs) or an In vivo
400 (Ruskinn). Cells were plated on glass dishes. Acute hyp-
oxia was considered up to 12 h whereas chronic exposure
was 16 to 48 h. Where no period of reoxygenation is indic-
ated, cells were harvested inside the chamber with equilibrat-
ed solutions.
Fluorescence-activated cell sorting analysis. Cells
were labeled with 10 μmol/L bromodeoxyuridine (BrdUrd)
(Sigma) 1 h before harvesting. Cells were processed for fluo-
rescence-activated cell sorting (FACS) analysis on a FACSort
flow cytometer (BD) after staining with mouse anti-BrdUrd
antibody (BD Biosciences) and Alexa-fluor 488–conjugated
goat anti-mouse IgG (Invitrogen). Quantification of cell
populations was done using WinMDI 2.9 software (Scripps
Research Institute).
siRNA transfection. p53 Silencer Select Validated siRNA
(Applied Biosystems Ambion) or Stealth RNAi negative control
(Invitrogen) duplexes, at a final concentration of 50 nmol/L,
were transfected into RKO cells using DhamaFECT (Thermo
Scientific) according to the manufacturer's instructions. 5′-3′
oligo sequence: GUAAUCUACUGGGACGGAAtt.
DNA fiber analysis. The DNA fiber technique was done as
described recently (17), with some specific modifications (see
Supplementary Fig. S2). Fiber spreads were examined using a
Radiance confocal microscope (Bio-Rad). Red (CldU) and
green (IdU) tracks were measured, and replication structures
quantified using ImageJ software (NIH). At least 100 replica-
tion tracks were measured and 200 replication structures
counted per condition per experiment.
Immunoblotting. Cells were lysed in UTB [9 mol/L urea,
75 mmol/L Tris-HCl (pH 7.5), and 0.15 mol/L β-mercaptoetha-
nol] and sonicated briefly. Preparation of chromatin-bound
protein extractswas done as described (18). Primary antibodies
were anti-MCM6, anti-MCM7, anti-Chk1, anti-Rad51, anti-p53,
and anti-actin (Santa Cruz Biotechnology); anti-RPA32 and anti-
MCM5 (Dr. C. Bauerschmidt, University of Oxford, Oxford, UK);
anti–proliferating cell nuclear antigen (PCNA; Calbiochem);
anti–HIF-1α (BD Biosciences); anti–pATM S1981 (Epitomics);
anti–pChk1 S317 (Cell Signaling Technology); and anti-TopBP1
(Abcam). Secondary antibodies were Alexa-fluor 680–conjugat-
ed goat anti-mouse and anti-rabbit IgG (Invitrogen). Detection
was done using the Odyssey IR imaging technology (LI-COR
Biosciences).
Immunofluorescence. RPA and 53BP1 staining was as
described (8). ssDNA and BrdUrd staining was carried
out as previously described (19). Cells were visualized usingCancer Res; 70(3) February 1, 2010a Nikon 90i microscope or a Radiance confocal microscope
(Bio-Rad).
Immunohistochemistry. Staining was done as described,
with some modifications (20); antigen retrieval was done us-
ing EDTA (pH 8.0) for Hydroxyprobe and EDTA (pH 9.0) for
CAIX and MCM6. Primary antibodies used were Hydroxy-
probe (Chemicon), anti-CAIX (M75; a gift from Dr. Pastore-
kova, Institute of Virology, Slovak Academy of Sciences,
Bratislava, Slovak Republic), and anti-MCM6 (Santa Cruz
Biotechnology).
Nucleotide quantification. The extracts for quantification
of nucleotide levels were carried in hypoxia with 3% tricar-
boxylic acid as described (21).
Quantitative reverse transcription-PCR. Quantitative real-
time PCR (qRT-PCR) was done as previously described (22),
using the Express SYBR GreenER qRT-PCR Supermix Kit (In-
vitrogen) following the manufacturer's recommendations.
Reactions were carried out in a 7500 Fast Real-time PCR De-
tection System (Applied Biosystems). Expression levels were
normalized to 18S rRNA and vascular endothelial growth fac-
tor was used as a positive control.
Reporter assay. Cells were transfected with the reporter
constructs (80 ng/well) using Lipofectamine transfection re-
agent (Invitrogen), along with pCMV-Renilla (0.2 ng/well) for
normalization. Firefly and Renilla luciferase activities were
measured using the Dual Glo Luciferase assay (Promega).
Statistical analysis. The statistical significance of differ-
ences between data sets was determined assessed by using
Student's t test. Statistical significance was assumed if
P < 0.05 or lower and is noted in the figures. Error bars
represent ±SE.
Results
DNA fiber analysis shows a block in replication
initiation and elongation in response to severe hypoxia.
Exposure to low oxygen levels results in a rapid cessation
of DNA synthesis in the absence of DNA damage (7). Oxygen
levels must be below 0.1% to induce an arrest, shown by
BrdUrd incorporation, and all subsequent experiments
were carried out at 0% to 0.02% O2 unless otherwise stated
(Fig. 1A; Supplementary Fig. S1). The oxygen dependency of
the arrest confirmed previous findings indicating that the S-
phase arrest is independent of HIF-1 (7). The rapid cessation
of DNA synthesis observed in response to severe levels of
hypoxia, described here and previously, used techniques such
as [3H]thymidine labeling or BrdUrd incorporation followed
by FACS analysis (7, 10, 23). These methods allow the overall
levels of DNA synthesis to be determined in a hypoxic cell
but do not give any information about the stage of replica-
tion at which the block occurs. To fully investigate hypoxia-
induced replication arrest, we have made use of the DNA
fiber technique, which allows visualization of individual
DNA strands and of different replication structures, as well
as measurement of the speed of ongoing replication forks
(Supplementary Fig. S2; ref. 24). RKO cells were exposed to
hypoxia for 4, 6, or 8 hours, and the replication structures ob-
served, quantified, and characterized as stalled forks, ongoingCancer Research
Reoxygenation-Induced Replication Restartforks, or new origins (Fig. 1B). It should be noted that a stalled
fork could also be a first-label termination, as these two struc-
tures are indistinguishable using this technique. After 4 hours
of hypoxia, the number of stalled/terminated forks increased
significantly and continued to accumulate over the following
4 hours. Concomitant with the increase in stalled forks, we
saw a decrease in ongoing forks. Importantly, we determined
that origin firing was significantly repressed in hypoxic condi-
tions, being nonexistent at the 8-hour time point.
We examined the rate of replication at ongoing fork
speeds, measuring both the average and median rates
(Fig. 1C). After 4 hours of hypoxia, the number of ongoing
forks had decreased by approximately 75% and the averagewww.aacrjournals.organd median rates of the remaining were decreased signifi-
cantly when compared with normoxic samples, with a shift
of the distribution severely toward the left. The fork speeds
were reduced further at 6 and 8 hours of hypoxic exposure,
being more than 15-fold reduced at the later time point when
compared with normoxic forks (0.05 versus 0.83 kb/min me-
dian rates; Fig. 1C and data not shown). Many of the hypoxic
ongoing forks have a barely detectable level of second label,
leading us to consider that they are not truly representative
of ongoing forks and that replication may be completely ab-
rogated in these conditions. These data show that DNA rep-
lication is blocked at both the initiation and elongation
phases in response to hypoxia.Figure 1. Hypoxia induces an S-phase replication arrest. Hypoxia levels pO2 <0.02, unless as indicated in A. A, RKO cells were exposed to decreasing
oxygen tensions for 8 h and labeled with BrdUrd. At least 200 cells were counted. B, RKO cells were exposed to hypoxia for the time points indicated and
DNA fibers were produced and scored. C, graphs represent the distribution of the fork rates for the second label [iododeoxyuridine (IdU)] for the
ongoing forks scored in B in normoxia (white) and hypoxia (gray) for the various hypoxic exposures. Inset, average and median fork rate values. D, HCT116
cells were exposed to hypoxia for up to 4 h or to hydroxyurea (HU; 2 mmol/L) for 1 h and processed to determine dNTP levels as described. Graph
represents fold changes of dNTPs comparing to normoxia.Cancer Res; 70(3) February 1, 2010 927
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928The ability of ribonucleotide reductase (RNR) to synthesize
the four deoxynucleotide triphosphates (dNTP) required for
DNA replication is dependent on a tyrosyl free radical within
the enzymes active site. This free radical is generated in an
oxygen-dependent manner and is therefore compromised un-
der hypoxic conditions (7, 23, 25). The ability of RNR to syn-
thesize the four dNTPs required for DNA replication is
dependent on a tyrosyl free radical within the enzymes active
site. This free radical is generated in an oxygen-dependent
manner and is therefore compromised under hypoxic condi-
tions (25). Nucleotide levels were measured by high-perfor-
mance liquid chromatography with spectrophotometric
detection in HCT116 cells exposed to hypoxia or to hy-
droxyurea as a control (Fig. 1D). Levels of dNTPs decreased
significantly (within 1 hour) in response to hypoxia, sug-
gesting that a loss of RNR activity under hypoxic conditions
could be the underlying cause or contribute to the hypoxia-
induced arrest. Significantly, dNTP levels did not decrease
during exposure to milder hypoxia (2% O2), which does
not induce replication arrest (data not shown). The absoluteCancer Res; 70(3) February 1, 2010levels of RNR protein were not found to change throughout
the experiment (data not shown). We also noted that energy
charge was not altered during the first 24 hours of hypoxic
treatment, indicating that decreased energy levels did not
contribute to the arrest (Supplementary Fig. S3). This sug-
gests a model whereby stalled forks arise during exposure
to hypoxia as a result of reduced levels of dNTPs and trigger
signaling pathways that inhibit origin firing, which is also re-
inforced by a lack of available nucleotides.
Replication restart is inhibited in response to chronic
hypoxia. The fate of hypoxia-arrested cells after reoxygena-
tion is significant because reoxygenation induces significant
levels of damage and major DNA repair pathways including
homologous recombination are inhibited during hypoxia/re-
oxygenation (9, 16, 26). To investigate replication restart in
this scenario, we pulse labeled RKO cells with BrdUrd to fol-
low S-phase cells through hypoxia and reoxygenation; cells
were scored as being unlabeled or labeled in the G1, S, or
G2 phase (Fig. 2A). Labeled S-phase cells exposed to hypoxia
(16 hours) failed to progress into G2 after reoxygenation,Figure 2. Chronic exposures to hypoxia impair replication restart after reoxygenation. Hypoxia levels pO2 <0.02. A, RKO cells were pulse labeled with
BrdUrd for 1 h in normoxic conditions and then harvested or exposed to hypoxia (16 h) or reoxygenation (16 h). BrdUrd-negative populations are
represented in red, and BrdUrd-positive populations in green. Percentages of different cellular populations were calculated (clockwise from top left: BrdUrd
positive G1, BrdUrd positive S, BrdUrd positive G2-M, BrdUrd negative G1, BrdUrd negative S, BrdUrd negative G2-M). B, replication- and repair-related
genes are downregulated in hypoxia, as determined by qRT-PCR. Graph represents gene expression changes relative to normoxia. C, spheroids
were stained for pimonidazole and (i) MCM6. (ii–v) U87 xenograft tumors treated with bevacizumab were stained for CAIX (vi and viii) and MCM6 (vii and ix).
Scale bars are indicated. Note that viii and ix are higher magnifications of the area shown in vi and vii, respectively.Cancer Research
Reoxygenation-Induced Replication Restartsuggesting that they were replication incompetent. Unlabeled
G1 cells were able to progress through to S phase after reox-
ygenation, suggesting that the hypoxia-induced G1 arrest is
not permanent and that the cells were viable (27). These
data indicate that chronic (16-hour) hypoxia exposure com-
promises the ability of the S-phase arrested cells to restart
DNA replication.
Previous microarray analysis in mouse embryonic fibro-
blasts suggested that a number of genes involved in DNA rep-
lication or repair were repressed in hypoxic conditions,
including Asf1b, MCM3, MCM4, MCM5, MCM6, MCM7,
Rad51 AP1, and Fen1 (22). In addition, polysomes were frac-
tionated after 24 or 48 hours of hypoxia followed by qRT-PCR
to identify gene products actively repressed in hypoxic con-
ditions (data not shown). Of the previously identified genes,www.aacrjournals.orgMCM3, MCM4, MCM5, and Asf1b were found to be repressed.
We have verified by qRT-PCR the repression of components
of the replicationmachinery under hypoxic conditions in a hu-
man cell line (Fig. 2B). Before proceeding further, we deter-
mined if hypoxia downregulation of key replication factors
occurred both at the protein level and in vivo. The MCM com-
plex (MCM2–MCM7) is loaded onto the chromatin in the G1
cell cycle phase to form the pre-replicative complexes, and
their helicase function is activated on initiation and required
for duplex unwinding during ongoing replication (28, 29).
First, the HCT116 cell line was grown as spheroids before
staining for MCM6 and the hypoxia marker pimonidazole
(Fig. 2C, i–v). The outer layers of the spheroids show a strong
nuclear stain of MCM6, whereas the cells surrounding the ne-
crotic core show no or greatly reduced levels of MCM6. As ex-
pected, the pattern of pimonidazole staining is inverse to that
seen for MCM6, that is, more positive toward the necrotic
core, indicating increasing levels of hypoxia. U87 cells were
grown as xenograft tumors and treated with the antiangio-
genic agent bevacizumab (30). The tumors were sectioned
and stained for CAIX and MCM6 (Fig. 2C, vi–ix). As expected,
viable cells within CAIX-positive regions showed decreased
levels of MCM6. In both models, we noticed that MCM6 levels
decrease before cells become obviously necrotic, supporting
our hypothesis that this is an active mechanism induced in
response to hypoxia and not a result of cell death. It should
be noted than in both systems, additional microenvironmen-
tal stresses not present in in vitro experiments may also play
a role in the repression of MCM6, for example, nutrient dep-
rivation (glucose and amino acids) and acidosis.
The E2F transcription factors have been shown to be impor-
tant for the cell growth–regulated expression of the MCM pro-
teins as well as for the repression of DNA repair during hypoxia
(31, 32). We investigated whether the hypoxia-induced repres-
sion of MCM proteins is E2F dependent, first, by using the
overexpression of human papillomavirus (HPV) E7. HPV E7
disrupts the E2F/pocket protein interaction and also targets
pocket proteins for degradation, thus interfering with E2F ac-
tivity (31). The expression levels ofMCM3 toMCM7were com-
pared in two RKO cell lines overexpressing E7 with a matched
control (Fig. 3A). In each case, the hypoxia-induced repression
was significantly alleviated by the presence of E7. To validate
the involvement of the E2Fs, we made use of aMCM6 reporter
construct with all the identified E2F binding sites mutated
(32). In response to hypoxia, we observed a 10- to 20-fold re-
pression of theMCM6 promoter in contrast to a 5× HRE lucif-
erase construct, which was induced 40-fold (Fig. 3B). Loss of
E2F binding significantly altered the repression of MCM6 in
response to hypoxia.
Our next step was to examine what effect the repression of
the MCM mRNAs had on the protein levels of MCM5, MCM6,
and MCM7 (Fig. 3C). In each case, the protein levels de-
creased and most significantly so after more chronic hypoxia
exposures, and it should be noted that this was not due to a
loss of S-phase cells (Fig. 2A). Because the protein levels
for the MCMs were not completely abrogated, potentially
due to the long half-life of these proteins (24 hours; ref.
33), we investigated whether the remaining MCM proteinsFigure 3. Chronic hypoxia leads to replisome disassembly. Hypoxia
levels pO2 <0.02. A, MCM gene expression repression is abrogated
in E7-expressing RKO cells. Graph represents gene expression changes
after 16-h hypoxia relative to normoxia. B, normalized luciferase
activity (firefly/Renilla) fold change for 16-h hypoxia relative to normoxic
controls for MCM6 promoter and respective E2F binding site mutant.
C, chromatin fractions and whole-cell extracts for MCM5, MCM6, MCM7,
and PCNA protein levels in normoxia and hypoxia for HCT116 cells.
NS, nonspecific band.Cancer Res; 70(3) February 1, 2010 929
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930were functional by determining their cellular location. Extrac-
tion of chromatin-bound proteins after chronic exposure to
hypoxia showed no association of MCM5, MCM6, or MCM7
with the chromatin, indicating a complete lack of replisome
function (Fig. 3C). The GINS proteins have been shown to in-Cancer Res; 70(3) February 1, 2010teract with the MCMs and are essential for DNA replication
(34). We investigated one of the GINS proteins, Psf2, and found
that total levels of Psf2 decreased rapidly in hypoxia. We have
also shown that, as predicted by the polysome assay, levels of
polymerase δ are repressed in hypoxic conditions and showFigure 4. DNA damage response is inhibited after chronic exposures to hypoxia. Hypoxia levels pO2 <0.02. A, representative Western blots showing
pATM S1981, TopBP1, Chk1, and pChk1 S317 levels for normoxia and hypoxia for HCT116 cells. B, Western blots for chromatin fractions and whole-cell
extracts for RPA protein levels, as in Fig. 3C. C, RKO cells were pulse labeled with BrdUrd for 1 h in normoxic conditions or exposed to hypoxia or to
hydroxyurea for 4 h. Data represent the fold change relative to normoxia of RPA foci–positive (gray) and BrdUrd-positive (white) cells of total cell number.
D, BrdUrd-labeled RKO cells exposed to hypoxia or to hydroxyurea for 6 h (19). Cells were then costained for BrdUrd and RPA. Data represent the
number of ssDNA (BrdUrd)-positive cells. At least 200 cells were counted per slide.Cancer Research
Reoxygenation-Induced Replication Restartdecreased chromatin association. This was not a general ef-
fect because PCNA remained chromatin bound during both
acute and chronic hypoxia. Taken together, these data indi-
cate that replication does not resume after chronic periods
of hypoxia due to an active disassembly of the replisome in-
cluding both the helicases and polymerases. The mechanism
behind this seems to be multifactorial. These data are sup-
portive of a transcriptional model in which activating E2Fs
are replaced on the MCM6 promoter with repressive E2Fs,
possibly E2F4 because it is the most sensitive to E7 expression
during hypoxia exposure (35). In addition, the MCM complex
is not retained at the replication fork potentially due to a loss
of interacting factors such as Psf2. The MCM complex has
been shown to be phosphorylated by ATM and ATR in re-www.aacrjournals.orgsponse to replication stress (MCM2 and MCM3), whereas
MCM7 has been shown to interact with ATR-interacting pro-
tein (36). Both the ATM and ATR kinases have been shown to
be active during hypoxia, and it is therefore plausible that
they contribute to MCM/replisome stability.
The accumulation of stalled replication forks or replicative
stress has been shown to activate the DDR. Acute hypoxia
exposure induced both ATM-S1981 and Chk1-S317, indicat-
ing the activity of both the ATM and ATR kinases. However,
these signals were lost or decreased with increasing hypoxia
exposure time (Fig. 4A). An integral step in the DDR to rep-
lication stress is the recognition of regions of ssDNA at
stalled forks and binding of RPA. The levels of RPA did
not change during hypoxia although there was a robustFigure 5. Reoxygenation-induced
replication restart occurs after acute
hypoxia exposure. Hypoxia levels
pO2 <0.02. A, chase experiment as
described in Fig. 2A. B, RKO cells were
exposed to 6-h hypoxia and reoxygenated
for 1 h and DNA fibers were produced. DNA
fibers were also prepared under normoxic
(norm) conditions. C, dNTP levels of RKO
cells exposed to hypoxia up to 6 h and
after 2-h reoxygenation. Average replication
fork speeds are indicated.Cancer Res; 70(3) February 1, 2010 931
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932ATM-dependent phosphorylation during acute exposure
that was absent after longer times (Fig. 4B; Supplementary
Fig. S4A and B). RPA was found to be chromatin associated
during acute, but not chronic, hypoxia. In support of this, we
found that RPA formed clear nuclear foci in response to hyp-
oxia but that these decreased as exposure time increased
(Fig. 4C). We then verified that the hypoxia-induced RPA foci
were indeed regions of ssDNA by costaining for BrdUrd in
labeled but nondenatured cells. The RPA foci and regions
of ssDNA completely colocalized (Fig. 4D). This prompted
us to count the number of cells positive for ssDNA by BrdUrd
staining. We found that this signal also decreases with
increasing exposure time, indicating that the signal whichCancer Res; 70(3) February 1, 2010initiates the DDR in response to hypoxia decreases after
extended periods, potentially due to slow or residual poly-
merase activity (37). These data are supportive of the hypox-
ia-induced DDR stabilizing the replisome during acute
exposure, potentially through phosphorylation of the MCM
complex, although we have not been able to verify this.
Cells exposed to acute hypoxia/reoxygenation remain
replication competent. In response to chronic exposure to
hypoxia, essential components of both the replication ma-
chinery and the DDR are repressed, which together lead
to the destabilization of the replication fork and prevent sub-
sequent restart. However, closer examination of our data
indicates that this may not be the case during shorter/acuteFigure 6. Characterization of
reoxygenation-induced replication restart
after acute hypoxia exposure. Hypoxia levels
pO2 <0.02. A, RKO cells, in the presence of
either vehicle alone or 100 nmol/L of the
Chk1 inhibitor Gö6976, were exposed to
6-h hypoxia and reoxygenated for 1 h and
DNA fibers were produced. B, IBR3 primary
and hTert immortalized fibroblasts were
exposed to 8-h hypoxia and reoxygenated
for 1 h, and DNA fibers produced. C, RKO cells
were transfected with either nontargeting siRNA
control (ntc) or p53 siRNA and the knockdown
was validated by Western blotting. Apoptosis
levels were determined by scoring cells
with characteristic nuclear morphology after
4′,6-diamidino-2-phenylindole staining. At least
200 cells were scored per sample.Cancer Research
Reoxygenation-Induced Replication Restartexposures (less than 12 hours). This raises the possibility that
cells that have undergone hypoxia-induced replication arrest
for shorter time periods might be capable of replication re-
start. To address this, we repeated the BrdUrd chase exper-
iment and found that labeled S-phase cells indeed progressed
through the cell cycle to G2 (Fig. 5A). To investigate this fur-
ther, we have again made use of the DNA fiber technique.
After acute exposure to hypoxia (6 hours), followed by reox-
ygenation, there was a significant increase in the number
of ongoing forks, an increase in the number of new origins,
and, as expected, a decrease in the number of stalled forks
(Fig. 5B). Using the mitotic shake-off technique, we have
ruled out any contribution of hypoxic G1 cells entering S
phase during reoxygenation in the fiber analysis (Supplemen-
tary Fig. S5A). Our data suggest that hypoxia-induced repli-
cation arrest is dependent on a decrease in dNTPs (Fig. 1D);
here, we investigated the dNTP levels after reoxygenation. As
previously, we saw a rapid and significant drop in all four
nucleotides in response to hypoxia; however, these levels re-
turned to normal within 2 hours of reoxygenation (Fig. 5C).
The same trend was also seen in HCT116 cells (data not
shown). Interestingly, we found that this correlated with re-
oxygenation-restarted replicating fork rates, which were
slower than those under normoxic conditions but returned
to normal within 2 hours after reoxygenation (Fig. 5C).
Despite reoxygenation-induced damage and activation of
the ATM/ATR signaling pathways, DNA replication resumes
during reoxygenation after acute hypoxia.
In addition to its role in regulating initiation and elonga-
tion in unperturbed cells, Chk1 has been shown to regulate
these processes following replication stress such as UV,
camptothecin, and hydroxyurea (18, 38–40). However, the
role of Chk1 in hypoxia-mediated arrest and reoxygena-
tion-induced restart is unknown. Pharmacologic inhibition
of Chk1 by treatment with Gö6976 did not significantly
change the number of ongoing forks, suggesting that Chk1
did not affect the hypoxia-induced arrest (Fig. 6A). Chk1 in-
hibition led to an overall decrease in average and median
speed even in the absence of hypoxic stress, which was
not further exacerbated by hypoxia exposure (data not
shown). During replication restart after acute hypoxia, how-
ever, loss of Chk1 led to a significant increase in the number
of new origins firing. This is supported by previous data in-
dicating a role for Chk1 in mediating the S-phase checkpoint
(41, 42). Again, this was verified using the mitotic shake-off
technique (Supplementary Fig. S5A).
We have considered that replication restart might be re-
stricted to tumor cell lines or possibly cells deficient in mis-
match repair as used here and have therefore investigated this
after reoxygenation in a nontransformed cell line (43). Prima-
ry 1BR3 and immortalized 1BR3 hTert cell lines were exposed
to hypoxia and reoxygenation (Fig. 6B). In both cases, cells
arrested in response to hypoxia as determined by a significant
increase in the number of stalled/terminated forks. In both
cases, Chk1 was also phosphorylated during hypoxia exposure
(data not shown). Reoxygenation-induced replication restart
was measured in both cell lines and seemed to be slightly
more robust in the 1BR3 compared with the 1BR3 hTert line.www.aacrjournals.orgThese data show that replication restart is not restricted to
transformed cell lines after reoxygenation but is a more
widespread phenomenon.
These findings led us to hypothesize that, to prevent reox-
ygenated cells undergoing replication restart from contribut-
ing to genomic instability, cell death might be induced. RKO
cells were treated with siRNA to p53 or a nontargeting con-
trol followed by 6 hours of hypoxia and reoxygenation, and
the levels of apoptosis were then determined (Fig. 6C). The
p53 status did not affect the level of hypoxia-induced apopto-
sis, which was approximately 5%. However, after reoxygena-
tion, there was a significant increase in apoptosis, which was
p53 dependent. These data indicate that p53-proficient cells
that undergo replication restart should be eradicated from
the tumor population by apoptosis, whereas those that have
p53-pathway mutations escape and contribute to genomic
instability.
Discussion
We have conclusively shown that replication is abrogated
in hypoxic conditions during both the initiation and elonga-
tion phases and that this correlates with decreasing dNTP
levels potentially resulting from decreased RNR activity. Until
now, it has been unclear whether cells exposed to hypoxia-
induced replication arrest are capable of completing S phase
after a reoxygenation event. Our data show that this is crit-
ically dependent on the exposure time to hypoxia.
Even when still viable, chronically arrested cells are inca-
pable of replication restart in response to reoxygenation and
therefore do not contribute to continued tumorigenesis. We
have attributed this to a complete loss of replisome stability
as well as hypoxia-mediated downregulation of the homolo-
gous recombination pathway. In contrast, our data show that
after shorter periods of hypoxia-induced replication arrest,
cells are able to resume replication in response to reoxygena-
tion. Importantly, this occurs in the presence of reactive ox-
ygen species–induced DNA damage and when essential DNA
repair pathways are somewhat inhibited, including nonho-
mologous end joining, mismatch repair, and homologous re-
combination (16, 26). A number of genes essential to these
repair pathways have been identified that are specifically re-
pressed during hypoxia, including Rad51, Rad52, BRCA1,
BRCA2, Ku70, DNA-PKcs, LigIV, MLH1, MSH2, and MSH6
(44–48). Together, these data indicate that cells that resume
DNA synthesis after a reoxygenating event do so in the pres-
ence of DNA damage and with impaired DNA repair capabil-
ities. Our data show that if these restarted cells retain p53
activity, they undergo apoptosis. However, because the ma-
jority of tumor cells harbor p53 or p53-pathway mutations,
it is more likely that cycling through periods of acute hypoxia
followed by reoxygenation will lead to an accumulation of
unrepaired lesions and increased genomic instability (15).
Encouragingly, our findings indicate that therapeutic op-
tions, such as bevacizumab, may enhance the potential ef-
fects of DNA repair/replication inhibitors and therefore
suggest that a combined approach may be an effective way
to target hypoxic regions. In addition, these findings suggestCancer Res; 70(3) February 1, 2010 933
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934that combining repair/replication inhibitors with therapies
with vascular normalization properties may effectively target
cells undergoing reoxygenation-induced replication restart.
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